A total of 412,120 doses of coronavirus vaccines arrived in Bosnia and Herzegovina, including today's delivery of 31,500 doses of Pfizer/BioNTech vaccines.

The Pfizer/BioNTech vaccines contingent that arrived at the Sarajevo International Airport today was purchased through the COVAX mechanism, through which Bosnia and Herzegovina preordered 1,232,000 vaccine doses.

On Tuesday, another 32,760 doses of Pfizer/BioNTech vaccines were delivered through the same mechanism and another 10,530 doses from the same manufacturer through the EU4Health program.

Through the COVAX mechanism, 49,800 doses of vaccines from AstraZeneca and Pfizer/BioNTech arrived in Bosnia and Herzegovina earlier, as well as another 10,530 doses of Pfizer/BioNTech vaccines through the EU4Health mechanism.

The Republic of Srpska entity procured 67,000 doses of Sputnik V vaccine and 80,000 doses of Sinofarm vaccine.

Bosnia and Herzegovina received donations of 40,000 doses of Sinovac vaccine from the Republic of Turkey, 40,000 doses of Astra Zenec vaccine from the Republic of Serbia, and 50,000 doses of Sinofarm vaccine as a donation from China.

Most of the vaccines that have arrived so far, 130,000 doses, came from the manufacturer Sinofarm, followed by 108,720 doses of Pfizer/BioNTech vaccines, 67,000 doses of Sputnik V vaccines, 66,400 doses of Astra Zeneca vaccines, and 40,000 doses of Sinovac vaccines. The total amount of vaccines that have arrived so far is sufficient to immunize 12 percent of the total population of Bosnia and Herzegovina.

In the coming period, in addition to prepaid doses of vaccines through the COVAX mechanism and those that should arrive through the EU4Health program, another 50,000 doses of vaccines donated by Malaysia, at the invitation of BiH Presidency member Šefik Džaferović, are expected to arrive, as well as 20,000 doses of Astra Zeneca vaccines donated by the Republic of Croatia, and 4,800 doses of vaccines as a donation from Slovenia.

Negotiations between the Government of the Federation of BiH and several manufacturers are underway to procure larger quantities of vaccines for the needs of immunization of the citizens of this entity.